ReviewBiomaterials2017
State of diagnosing infectious pathogens using colloidal nanomaterials.
Review in Biomaterials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Detection of respiratory pathogens in infants using targeted next-generation sequencing versus conventional methods in Qingdao.BMC infectious diseases · 2025Article
- A Concise Review of the Control and Assessment of Magnetic Affinity Particle Assembly for Live Cell Analyses: State of the Art and Challenges.Materials (Basel, Switzerland) · 2025Review
- Recent Developments in Lateral Flow Assays forPathogens (Basel, Switzerland) · 2023Review
- Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives.Drug delivery · 2022Review
- Engineered multivalent self-assembled binder protein against SARS-CoV-2 RBD.Biochemical engineering journal · 2022Article
- Development of gold nanoparticles-lateral flow test as a novel field diagnostic assay for detecting foot-and-mouth disease and lumpy skin disease viruses.Iranian journal of microbiology · 2022Article
- Antibiotic-functionalized gold nanoparticles for the detection of active β-lactamases.Nanoscale advances · 2022Article
- Review
- Nuclear magnetic resonance immunoassay of tetanus antibodies based on the displacement of magnetic nanoparticles.Analytical and bioanalytical chemistry · 2021Article
- Controlled copper in situ growth-amplified lateral flow sensors for sensitive, reliable, and field-deployable infectious disease diagnostics.Biosensors & bioelectronics · 2021Article
- Nanotools for Sepsis Diagnosis and Treatment.Advanced healthcare materials · 2021Review
- Will Technology Rather Than Vaccination Be the Way to Control Pandemics?Infectious microbes & diseases · 2020Article
- The challenge of recognising sepsis: Future nanotechnology solutions.Journal of the Intensive Care Society · 2020Review
- Magnetic Particles for Advanced Molecular Diagnosis.Materials (Basel, Switzerland) · 2019Review
- Careers in nanomedicine and drug delivery.Advanced drug delivery reviews · 2019Review
- Mapping of the available standards against the regulatory needs for nanomedicines.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infectious diseases are a major global threat that accounts for one of the leading causes of global mortality and morbidity. Prompt diagnosis is a crucial first step in the management of infectious threats, which aims to quarantine infected patients to avoid contacts with healthy individuals and deliver effective treatments prior to further spread of diseases. This review article discusses current advances of diagnostic systems using colloidal nanomaterials (e.g., gold nanoparticles, quantum dots, magnetic nanoparticles) for identifying and differentiating infectious pathogens. The challenges involved in the clinical translation of these emerging nanotechnology based diagnostic devices will also be discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.